SMR Q3 Earnings Call Highlights Shift to Module Manufacturing

What happened

NuScale held its Q3 earnings call, emphasizing a strategic shift from reactor development to module manufacturing, supported by $1.9 billion in liquidity. Management reiterated that negotiations with TVA remain the critical pathway to securing commercial orders. However, the company still has no binding module delivery contract, and revenue remains minimal, while Romania's financing progress has stalled. The shift to manufacturing signals supply-chain readiness but does not alter the fundamental lack of customer commitments. The stock's current valuation already reflects the liquidity cushion and U.S. small modular reactor optionality.

Implication

Investors should remain cautious as the company still lacks binding contracts, and the $1.9 billion liquidity provides runway but also reflects heavy dilution. The key risk remains TVA negotiations failing to convert to a power purchase agreement, and Romania's financing stall. Until a concrete order is announced, the stock's speculative premium may not be justified at current levels. The shift to manufacturing suggests confidence in the supply chain but could also lead to higher cash burn without revenue. A prudent stance is to wait for clearer commercial validation or a more attractive entry price near $8.

Thesis delta

The core thesis remains unchanged: NuScale's value hinges on converting licensing advantage into binding customer contracts. The shift to module manufacturing is a notable operational development but does not yet provide evidence of commercial demand. No change to the WAIT rating or valuation range is warranted based on this update.